These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26883563)

  • 1. Efficacy and Safety of Adjuvant Proton Therapy Combined With Surgery for Chondrosarcoma of the Skull Base: A Retrospective, Population-Based Study.
    Feuvret L; Bracci S; Calugaru V; Bolle S; Mammar H; De Marzi L; Bresson D; Habrand JL; Mazeron JJ; Dendale R; Noël G
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):312-321. PubMed ID: 26883563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery and protontherapy in Grade I and II skull base chondrosarcoma: A comparative retrospective study.
    Simon F; Feuvret L; Bresson D; Guichard JP; El Zein S; Bernat AL; Labidi M; Calugaru V; Froelich S; Herman P; Verillaud B
    PLoS One; 2018; 13(12):e0208786. PubMed ID: 30557382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report.
    Ares C; Hug EB; Lomax AJ; Bolsi A; Timmermann B; Rutz HP; Schuller JC; Pedroni E; Goitein G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1111-8. PubMed ID: 19386442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute.
    Weber DC; Badiyan S; Malyapa R; Albertini F; Bolsi A; Lomax AJ; Schneider R
    Neuro Oncol; 2016 Feb; 18(2):236-43. PubMed ID: 26323608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High control rates of proton- and carbon-ion-beam treatment with intensity-modulated active raster scanning in 101 patients with skull base chondrosarcoma at the Heidelberg Ion Beam Therapy Center.
    Mattke M; Vogt K; Bougatf N; Welzel T; Oelmann-Avendano J; Hauswald H; Jensen A; Ellerbrock M; Jäkel O; Haberer T; Herfarth K; Debus J; Uhl M
    Cancer; 2018 May; 124(9):2036-2044. PubMed ID: 29469932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure.
    Noël G; Habrand JL; Jauffret E; de Crevoisier R; Dederke S; Mammar H; Haie-Méder C; Pontvert D; Hasboun D; Ferrand R; Boisserie G; Beaudré A; Gaboriaud G; Guedea F; Petriz L; Mazeron JJ
    Strahlenther Onkol; 2003 Apr; 179(4):241-8. PubMed ID: 12707713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spot-scanning proton radiation therapy for pediatric chordoma and chondrosarcoma: clinical outcome of 26 patients treated at paul scherrer institute.
    Rombi B; Ares C; Hug EB; Schneider R; Goitein G; Staab A; Albertini F; Bolsi A; Lomax AJ; Timmermann B
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):578-84. PubMed ID: 23582853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: the Centre de Protonthérapie D'Orsay experience.
    Noël G; Habrand JL; Mammar H; Pontvert D; Haie-Méder C; Hasboun D; Moisson P; Ferrand R; Beaudré A; Boisserie G; Gaboriaud G; Mazal A; Kérody K; Schlienger M; Mazeron JJ
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):392-8. PubMed ID: 11567813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton therapy for skull-base chondrosarcoma, a single-institution outcomes study.
    Holtzman AL; Rotondo RL; Rutenberg MS; Indelicato DJ; Mercado CE; Rao D; Tavanaiepour D; Morris CG; Louis D; Flampouri S; Mendenhall WM
    J Neurooncol; 2019 May; 142(3):557-563. PubMed ID: 30827010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endoscopic transnasal surgery for skull base chondrosarcoma: a retrospective analysis of 19 cases at a single institution.
    Hasegawa H; Shin M; Kondo K; Hanakita S; Mukasa A; Kin T; Saito N
    J Neurosurg; 2018 May; 128(5):1438-1447. PubMed ID: 28686110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors.
    Pehlivan B; Ares C; Lomax AJ; Stadelmann O; Goitein G; Timmermann B; Schneider RA; Hug EB
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1432-40. PubMed ID: 22349042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine.
    Guan X; Gao J; Hu J; Hu W; Yang J; Qiu X; Hu C; Kong L; Lu JJ
    Radiat Oncol; 2019 Nov; 14(1):206. PubMed ID: 31752953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity.
    Gordon K; Gulidov I; Koryakin S; Smyk D; Makeenkova T; Gogolin D; Lepilina O; Golovanova O; Semenov A; Dujenko S; Medvedeva K; Mardynsky Y
    Radiat Oncol; 2021 Dec; 16(1):238. PubMed ID: 34930352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
    Grosshans DR; Zhu XR; Melancon A; Allen PK; Poenisch F; Palmer M; McAleer MF; McGovern SL; Gillin M; DeMonte F; Chang EL; Brown PD; Mahajan A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):540-6. PubMed ID: 25304948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: first report of long-term results.
    Uhl M; Mattke M; Welzel T; Oelmann J; Habl G; Jensen AD; Ellerbrock M; Haberer T; Herfarth KK; Debus J
    Cancer; 2014 May; 120(10):1579-85. PubMed ID: 24500784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull.
    Santoni R; Liebsch N; Finkelstein DM; Hug E; Hanssens P; Goitein M; Smith AR; O'Farrell D; Efird JT; Fullerton B; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):59-68. PubMed ID: 9588918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term outcome of skull-base chondrosarcoma patients treated with high-dose proton therapy with or without conventional radiation therapy.
    Weber DC; Murray F; Combescure C; Calugaru V; Alapetite C; Albertini F; Bolle S; Goudjil F; Pica A; Walser M; Mammar H; Bachtiary B; Lomax T; Noël G; Dendale R; Feuvret L
    Radiother Oncol; 2018 Dec; 129(3):520-526. PubMed ID: 30021697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton radiation therapy for chordomas and chondrosarcomas of the skull base.
    Hug EB; Loredo LN; Slater JD; DeVries A; Grove RI; Schaefer RA; Rosenberg AE; Slater JM
    J Neurosurg; 1999 Sep; 91(3):432-9. PubMed ID: 10470818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton radiation therapy for chordomas and chondrosarcomas of the skull base.
    Hug EB; Slater JD
    Neurosurg Clin N Am; 2000 Oct; 11(4):627-38. PubMed ID: 11082173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy.
    Basler L; Poel R; Schröder C; Bolsi A; Lomax A; Tanadini-Lang S; Guckenberger M; Weber DC
    Radiat Oncol; 2020 Nov; 15(1):266. PubMed ID: 33198810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.